1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oxytocin Receptor Antagonists Consumption 2016-2026
2.1.2 Oxytocin Receptor Antagonists Consumption CAGR by Region
2.2 Oxytocin Receptor Antagonists Segment by Type
2.2.1 Non-Peptide and Orally Active Oxytocin Receptor Antagonist
2.2.2 High Affinity Human Oxytocin (OT) Receptor Antagonist
2.3 Oxytocin Receptor Antagonists Sales by Type
2.3.1 Global Oxytocin Receptor Antagonists Sales Market Share by Type (2016-2021)
2.3.2 Global Oxytocin Receptor Antagonists Revenue and Market Share by Type (2016-2021)
2.3.3 Global Oxytocin Receptor Antagonists Sale Price by Type (2016-2021)
2.4 Oxytocin Receptor Antagonists Segment by Application
2.4.1 Animals
2.4.2 People
2.5 Oxytocin Receptor Antagonists Sales by Application
2.5.1 Global Oxytocin Receptor Antagonists Sale Market Share by Application (2016-2021)
2.5.2 Global Oxytocin Receptor Antagonists Revenue and Market Share by Application (2016-2021)
2.5.3 Global Oxytocin Receptor Antagonists Sale Price by Application (2016-2021)
3 Global Oxytocin Receptor Antagonists by Company
3.1 Global Oxytocin Receptor Antagonists Sales Market Share by Company
3.1.1 Global Oxytocin Receptor Antagonists Sales by Company (2019-2021)
3.1.2 Global Oxytocin Receptor Antagonists Sales Market Share by Company (2019-2021)
3.2 Global Oxytocin Receptor Antagonists Revenue Market Share by Company
3.2.1 Global Oxytocin Receptor Antagonists Revenue by Company (2019-2021)
3.2.2 Global Oxytocin Receptor Antagonists Revenue Market Share by Company (2019-2021)
3.3 Global Oxytocin Receptor Antagonists Sale Price by Company
3.4 Global Manufacturers Oxytocin Receptor Antagonists Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oxytocin Receptor Antagonists Product Location Distribution
3.4.2 Players Oxytocin Receptor Antagonists Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Oxytocin Receptor Antagonists by Region
4.1 Global Oxytocin Receptor Antagonists by Region
4.1.1 Global Oxytocin Receptor Antagonists Sales by Region
4.1.2 Global Oxytocin Receptor Antagonists Revenue by Region
4.2 Americas Oxytocin Receptor Antagonists Sales Growth
4.3 APAC Oxytocin Receptor Antagonists Sales Growth
4.4 Europe Oxytocin Receptor Antagonists Sales Growth
4.5 Middle East & Africa Oxytocin Receptor Antagonists Sales Growth
5 Americas
5.1 Americas Oxytocin Receptor Antagonists Sales by Country
5.1.1 Americas Oxytocin Receptor Antagonists Sales by Country (2016-2021)
5.1.2 Americas Oxytocin Receptor Antagonists Revenue by Country (2016-2021)
5.2 Americas Oxytocin Receptor Antagonists Sales by Type
5.3 Americas Oxytocin Receptor Antagonists Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oxytocin Receptor Antagonists Sales by Region
6.1.1 APAC Oxytocin Receptor Antagonists Sales by Region (2016-2021)
6.1.2 APAC Oxytocin Receptor Antagonists Revenue by Region (2016-2021)
6.2 APAC Oxytocin Receptor Antagonists Sales by Type
6.3 APAC Oxytocin Receptor Antagonists Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Oxytocin Receptor Antagonists by Country
7.1.1 Europe Oxytocin Receptor Antagonists Sales by Country (2016-2021)
7.1.2 Europe Oxytocin Receptor Antagonists Revenue by Country (2016-2021)
7.2 Europe Oxytocin Receptor Antagonists Sales by Type
7.3 Europe Oxytocin Receptor Antagonists Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oxytocin Receptor Antagonists by Country
8.1.1 Middle East & Africa Oxytocin Receptor Antagonists Sales by Country (2016-2021)
8.1.2 Middle East & Africa Oxytocin Receptor Antagonists Revenue by Country (2016-2021)
8.2 Middle East & Africa Oxytocin Receptor Antagonists Sales by Type
8.3 Middle East & Africa Oxytocin Receptor Antagonists Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Oxytocin Receptor Antagonists Distributors
10.3 Oxytocin Receptor Antagonists Customer
11 Global Oxytocin Receptor Antagonists Market Forecast
11.1 Global Oxytocin Receptor Antagonists Forecast by Region
11.1.1 Global Oxytocin Receptor Antagonists Forecast by Regions (2021-2026)
11.2.2 Global Oxytocin Receptor Antagonists Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Oxytocin Receptor Antagonists Forecast by Type
11.7 Global Oxytocin Receptor Antagonists Forecast by Application
12 Key Players Analysis
12.1 Ferring
12.1.1 Ferring Ferring Company Information
12.1.2 Ferring Oxytocin Receptor Antagonists Product Offered
12.1.3 Ferring Oxytocin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Ferring Main Business Overview
12.1.5 Ferring Latest Developments
12.2 Sun Pharmaceutical
12.2.1 Sun Pharmaceutical Company Information
12.2.2 Sun Pharmaceutical Oxytocin Receptor Antagonists Product Offered
12.2.3 Sun Pharmaceutical Oxytocin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Sun Pharmaceutical Main Business Overview
12.2.5 Sun Pharmaceutical Latest Developments
12.3 Biopas
12.3.1 Biopas Company Information
12.3.2 Biopas Oxytocin Receptor Antagonists Product Offered
12.3.3 Biopas Oxytocin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Biopas Main Business Overview
12.3.5 Biopas Latest Developments
12.4 PolyPeptide
12.4.1 PolyPeptide Company Information
12.4.2 PolyPeptide Oxytocin Receptor Antagonists Product Offered
12.4.3 PolyPeptide Oxytocin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 PolyPeptide Main Business Overview
12.4.5 PolyPeptide Latest Developments
12.5 CS Bio
12.5.1 CS Bio Company Information
12.5.2 CS Bio Oxytocin Receptor Antagonists Product Offered
12.5.3 CS Bio Oxytocin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 CS Bio Main Business Overview
12.5.5 CS Bio Latest Developments
…
13 Research Findings and Conclusion
List of TablesTable 1. Oxytocin Receptor Antagonists Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Non-Peptide and Orally Active Oxytocin Receptor Antagonist
Table 3. Major Players of High Affinity Human Oxytocin (OT) Receptor Antagonist
Table 4. Global Oxytocin Receptor Antagonists Sales by Type (2016-2021) & (Kiloton)
Table 5. Global Oxytocin Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 6. Global Oxytocin Receptor Antagonists Revenue by Type (2016-2021) & ($ million)
Table 7. Global Oxytocin Receptor Antagonists Revenue Market Share by Type (2016-2021)
Table 8. Global Oxytocin Receptor Antagonists Sale Price by Type (2016-2021)
Table 9. Global Oxytocin Receptor Antagonists Sales by Application (2016-2021) & (Kiloton)
Table 10. Global Oxytocin Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 11. Global Oxytocin Receptor Antagonists Value by Application (2016-2021)
Table 12. Global Oxytocin Receptor Antagonists Revenue Market Share by Application (2016-2021)
Table 13. Global Oxytocin Receptor Antagonists Sale Price by Application (2016-2021)
Table 14. Global Oxytocin Receptor Antagonists Sales by Company (2019-2021) & (Kiloton)
Table 15. Global Oxytocin Receptor Antagonists Sales Market Share by Company (2019-2021)
Table 16. Global Oxytocin Receptor Antagonists Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Oxytocin Receptor Antagonists Revenue Market Share by Company (2019-2021)
Table 18. Global Oxytocin Receptor Antagonists Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Oxytocin Receptor Antagonists Producing Area Distribution and Sales Area
Table 20. Players Oxytocin Receptor Antagonists Products Offered
Table 21. Oxytocin Receptor Antagonists Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Oxytocin Receptor Antagonists Sales by Region (2016-2021) (Kiloton)
Table 25. Global Oxytocin Receptor Antagonists Sales Market Share by Region (2016-2021)
Table 26. Global Oxytocin Receptor Antagonists Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Oxytocin Receptor Antagonists Revenue Market Share by Region (2016-2021)
Table 28. Americas Oxytocin Receptor Antagonists Sales by Country (2016-2021) & (Kiloton)
Table 29. Americas Oxytocin Receptor Antagonists Sales Market Share by Country (2016-2021)
Table 30. Americas Oxytocin Receptor Antagonists Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Oxytocin Receptor Antagonists Revenue Market Share by Country (2016-2021)
Table 32. Americas Oxytocin Receptor Antagonists Sales by Type (2016-2021) & (Kiloton)
Table 33. Americas Oxytocin Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 34. Americas Oxytocin Receptor Antagonists Sales by Application (2016-2021) & (Kiloton)
Table 35. Americas Oxytocin Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 36. APAC Oxytocin Receptor Antagonists Sales by Region (2016-2021) & (Kiloton)
Table 37. APAC Oxytocin Receptor Antagonists Sales Market Share by Region (2016-2021)
Table 38. APAC Oxytocin Receptor Antagonists Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Oxytocin Receptor Antagonists Revenue Market Share by Region (2016-2021)
Table 40. APAC Oxytocin Receptor Antagonists Sales by Type (2016-2021) & (Kiloton)
Table 41. APAC Oxytocin Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 42. APAC Oxytocin Receptor Antagonists Sales by Application (2016-2021) & (Kiloton)
Table 43. APAC Oxytocin Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 44. Europe Oxytocin Receptor Antagonists Sales by Country (2016-2021) & (Kiloton)
Table 45. Europe Oxytocin Receptor Antagonists Sales Market Share by Country (2016-2021)
Table 46. Europe Oxytocin Receptor Antagonists Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Oxytocin Receptor Antagonists Revenue Market Share by Country (2016-2021)
Table 48. Europe Oxytocin Receptor Antagonists Sales by Type (2016-2021) & (Kiloton)
Table 49. Europe Oxytocin Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 50. Europe Oxytocin Receptor Antagonists Sales by Application (2016-2021) & (Kiloton)
Table 51. Europe Oxytocin Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Oxytocin Receptor Antagonists Sales by Country (2016-2021) & (Kiloton)
Table 53. Middle East & Africa Oxytocin Receptor Antagonists Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Oxytocin Receptor Antagonists Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Oxytocin Receptor Antagonists Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Oxytocin Receptor Antagonists Sales by Type (2016-2021) & (Kiloton)
Table 57. Middle East & Africa Oxytocin Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Oxytocin Receptor Antagonists Sales by Application (2016-2021) & (Kiloton)
Table 59. Middle East & Africa Oxytocin Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 60. Global Oxytocin Receptor Antagonists Sales Forecast by Type (2021-2026) & (Kiloton)
Table 61. Global Oxytocin Receptor Antagonists Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Oxytocin Receptor Antagonists Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Oxytocin Receptor Antagonists Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Oxytocin Receptor Antagonists Sales Forecast by Application (2021-2026) & (Kiloton)
Table 65. Global Oxytocin Receptor Antagonists Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Oxytocin Receptor Antagonists Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Oxytocin Receptor Antagonists Revenue Market Share Forecast by Application (2021-2026)
Table 68. Ferring Basic Information, Oxytocin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 69. Ferring Oxytocin Receptor Antagonists Product Offered
Table 70. Ferring Oxytocin Receptor Antagonists Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 71. Ferring Main Business
Table 72. Ferring Latest Developments
Table 73. Sun Pharmaceutical Basic Information, Oxytocin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 74. Sun Pharmaceutical Oxytocin Receptor Antagonists Product Offered
Table 75. Sun Pharmaceutical Oxytocin Receptor Antagonists Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 76. Sun Pharmaceutical Main Business
Table 77. Sun Pharmaceutical Latest Developments
Table 78. Biopas Basic Information, Oxytocin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 79. Biopas Oxytocin Receptor Antagonists Product Offered
Table 80. Biopas Oxytocin Receptor Antagonists Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 81. Biopas Main Business
Table 82. Biopas Latest Developments
Table 83. PolyPeptide Basic Information, Oxytocin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 84. PolyPeptide Oxytocin Receptor Antagonists Product Offered
Table 85. PolyPeptide Oxytocin Receptor Antagonists Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 86. PolyPeptide Main Business
Table 87. PolyPeptide Latest Developments
Table 88. CS Bio Basic Information, Oxytocin Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 89. CS Bio Oxytocin Receptor Antagonists Product Offered
Table 90. CS Bio Oxytocin Receptor Antagonists Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2021E)
Table 91. CS Bio Main Business
Table 92. CS Bio Latest Developments
List of Figures
Figure 1. Picture of Oxytocin Receptor Antagonists
Figure 2. Oxytocin Receptor Antagonists Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oxytocin Receptor Antagonists Sales Growth Rate 2016-2026 (Kiloton)
Figure 7. Global Oxytocin Receptor Antagonists Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Oxytocin Receptor Antagonists Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Non-Peptide and Orally Active Oxytocin Receptor Antagonist
Figure 10. Product Picture of High Affinity Human Oxytocin (OT) Receptor Antagonist
Figure 11. Global Oxytocin Receptor Antagonists Sales Market Share by Type in 2020
Figure 12. Global Oxytocin Receptor Antagonists Revenue Market Share by Type (2016-2021)
Figure 13. Oxytocin Receptor Antagonists Consumed in Animals
Figure 14. Global Oxytocin Receptor Antagonists Market: Animals (2016-2021) & (Kiloton)
Figure 15. Oxytocin Receptor Antagonists Consumed in People
Figure 16. Global Oxytocin Receptor Antagonists Market: People (2016-2021) & (Kiloton)
Figure 17. Global Oxytocin Receptor Antagonists Sales Market Share by Application (2016-2021)
Figure 18. Global Oxytocin Receptor Antagonists Revenue Market Share by Application in 2020
Figure 19. Global Oxytocin Receptor Antagonists Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Oxytocin Receptor Antagonists Revenue Market Share by Company in 2020
Figure 21. Global Oxytocin Receptor Antagonists Sales Market Share by Regions (2016-2021)
Figure 22. Global Oxytocin Receptor Antagonists Revenue Market Share by Region in 2020
Figure 23. Americas Oxytocin Receptor Antagonists Sales 2016-2021 (Kiloton)
Figure 24. Americas Oxytocin Receptor Antagonists Revenue 2016-2021 ($ Millions)
Figure 25. APAC Oxytocin Receptor Antagonists Sales 2016-2021 (Kiloton)
Figure 26. APAC Oxytocin Receptor Antagonists Revenue 2016-2021 ($ Millions)
Figure 27. Europe Oxytocin Receptor Antagonists Sales 2016-2021 (Kiloton)
Figure 28. Europe Oxytocin Receptor Antagonists Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Oxytocin Receptor Antagonists Sales 2016-2021 (Kiloton)
Figure 30. Middle East & Africa Oxytocin Receptor Antagonists Revenue 2016-2021 ($ Millions)
Figure 31. Americas Oxytocin Receptor Antagonists Sales Market Share by Country in 2020
Figure 32. Americas Oxytocin Receptor Antagonists Revenue Market Share by Country in 2020
Figure 33. Americas Oxytocin Receptor Antagonists Sales Market Share by Type in 2020
Figure 34. Americas Oxytocin Receptor Antagonists Sales Market Share by Application in 2020
Figure 35. United States Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Oxytocin Receptor Antagonists Sales Market Share by Region in 2020
Figure 40. APAC Oxytocin Receptor Antagonists Revenue Market Share by Regions in 2020
Figure 41. APAC Oxytocin Receptor Antagonists Sales Market Share by Type in 2020
Figure 42. APAC Oxytocin Receptor Antagonists Sales Market Share by Application in 2020
Figure 43. China Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Oxytocin Receptor Antagonists Sales Market Share by Country in 2020
Figure 50. Europe Oxytocin Receptor Antagonists Revenue Market Share by Country in 2020
Figure 51. Europe Oxytocin Receptor Antagonists Sales Market Share by Type in 2020
Figure 52. Europe Oxytocin Receptor Antagonists Sales Market Share by Application in 2020
Figure 53. Germany Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Oxytocin Receptor Antagonists Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Oxytocin Receptor Antagonists Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Oxytocin Receptor Antagonists Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Oxytocin Receptor Antagonists Sales Market Share by Application in 2020
Figure 62. Egypt Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Oxytocin Receptor Antagonists Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
【免責事項】
https://www.globalresearch.jp/disclaimer